Possibia

233

Last Update Posted: 2005-08-17

Recruiting has ended

All Genders

accepted

34 Years-51 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Alternate Day Buprenorphine Administration, Phase X - 15

The purpose of this study is to determine how subjects will make changes in the amount of medication received when given a monetary alternative to buprenorphine.

Eligibility

Relevant conditions:

Opioid-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov